Review Article

A review on Trichomonas vaginalis infections in women from Africa

Nonkululeko Mabaso, Nathlee S. Abbai
Southern African Journal of Infectious Diseases | Vol 36, No 1 | a254 | DOI: https://doi.org/10.4102/sajid.v36i1.254 | © Nonkululeko Mabaso, Nathlee S. Abbai | This work is licensed under CC Attribution 4.0
Submitted: 01 October 2020 | Published: 10 June 2021

About the author(s)

Nonkululeko Mabaso, School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
Nathlee S. Abbai, School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

Abstract

Background: Trichomoniasis is the most common sexually transmitted infection (STI) with an estimated annual incidence of 276.4 million cases globally and about 30 million cases in sub-Saharan Africa. Trichomoniasis has been found to be associated with various health complications including pelvic inflammatory disease (PID), significant pregnancy complications, cervical cancer, prostatitis, infertility and the acquisition of human immunodeficiency virus (HIV).

Aim: Despite being a highly prevalent infection in the African continent, there is no review article published that solely focusses on Trichomonas vaginalis (T. vaginalis) infections in women from Africa. This review aims to fill this gap in the literature.

Method: An electronic search of online databases was used to identify and extract relevant research articles related to the epidemiology, health complications and treatment associated with T. vaginalis in women from Africa.

Results: Within the African continent, South Africa has reported the highest prevalence rate for this infection. A combination of sociodemographic, behavioural and biological factors has been shown to be associated with infection. Trichomonas vaginalis infection is associated with the acquisition of HIV, cervical cancer and PIDs in various female populations across the continent. Emerging patterns of resistance to metronidazole have been reported in women from South Africa. Currently, there is no effective vaccine against this pathogen despite efforts at vaccine development.

Conclusion: Based on the high prevalence and health consequences associated with T. vaginalis, there is a need for improved screening programmes that will lead to early diagnosis, detection of asymptomatic infections and effective treatment regimens.


Keywords

Trichomonas vaginalis; Africa; epidemiology; drug resistance; health complications

Metrics

Total abstract views: 6539
Total article views: 10603

 

Crossref Citations

1. Molecular detection of Trichomonas vaginalis from women in Babylon province, Iraq
R. M. J. Eanzi, N. A. M. Al-Kaabi
Regulatory Mechanisms in Biosystems  vol: 15  issue: 4  first page: 976  year: 2024  
doi: 10.15421/0224143

2. Toward an ethical future for orphan drugs: balancing access, affordability, and innovation
Esther Ugo Alum, Joseph Enyia Ekpang II, Patience Owere Ekpang, Christine Ainebyoona, Kingsley Ekene Nwagu, Olisa Alfred Nwuruku, Kibuuka Muhammad
Journal of Medical Economics  vol: 28  issue: 1  first page: 1869  year: 2025  
doi: 10.1080/13696998.2025.2577514

3. Prevalence of Trichomoniasis in Women Attending Health Centers in Asadabad City, West of Iran, During 2021-2022
Ali Azimi Kohn, Faeze Foroughi-Parvar, Sepehr Matini, Mohammad Matini
Avicenna Journal of Clinical Microbiology and Infection  vol: 11  issue: 1  first page: 38  year: 2024  
doi: 10.34172/ajcmi.3464

4. Natural product-based inhibitors of quorum sensing: A novel approach to combat antibiotic resistance
Esther Ugo Alum, Bashar Haruna Gulumbe, Sylvester Chibueze Izah, Daniel Ejim Uti, Patrick Maduabuchi Aja, Ikechuku Okorie Igwenyi, Christian Emeka Offor
Biochemistry and Biophysics Reports  vol: 43  first page: 102111  year: 2025  
doi: 10.1016/j.bbrep.2025.102111

5. Global burden of trichomoniasis: current status, trends, and projections (1990–2021)
Xingmin Wei, Lu Liu, Kun Liu, Xiaoang Qin, Jianjun Wu, Lou Jiang, Longjian Shang
Frontiers in Public Health  vol: 13  year: 2025  
doi: 10.3389/fpubh.2025.1530227

6. Prevalence and Genotype of Trichomonas vaginalis among Men in Xinxiang City, Henan Province, China
Zhenchao Zhang, Yuhui Sang, Pucheng Wu, Yujia Shang, Lesong Li, Yujuan Duan, Linfei Zhao, Minghui Gao, Lihua Guo, Xiaowei Tian, Zhenke Yang, Shuai Wang, Lixia Hao, Xuefang Mei, Jianbing Mu
Journal of Tropical Medicine  vol: 2023  first page: 1  year: 2023  
doi: 10.1155/2023/4119956

7. Research progress of extracellular vesicles in the pathogenesis of type IIIA chronic prostatitis
Le Cheng, Peiyue Luo, Wei Li, Qi Chen, Lifeng Gan, Fangtao Zhang, Liying Zheng, Biao Qian
Frontiers in Immunology  vol: 16  year: 2025  
doi: 10.3389/fimmu.2025.1496055

8. Trichomonas vaginalis and Mycoplasma co-infection among women received in a microbiology laboratory in Dakar
Mame C. Seck, Papa A.T. Gueye, Cheikh Faye, Pasca E. Engo, Khadim Diongue, Mouhamadou Ndiaye, Aida S. Badiane, Daouda Ndiaye
African Journal of Parasitology, Mycology and Entomology  vol: 2  issue: 1  first page: 1  year: 2024  
doi: 10.35995/ajpme2010003

9. Metagenomic next-generation sequencing in diagnosing perinephric abscess infection caused by Trichomonas vaginalis
Sifen Lu, Guiming Xie, Mei Yuan, Yongzhao Zhou, Jing Wang, Juan Jiang, Wengeng Zhang, Xiaoyan He, Bojiang Chen
Precision Clinical Medicine  vol: 7  issue: 4  year: 2024  
doi: 10.1093/pcmedi/pbae027

10. Association between the infections of Trichomonas vaginalis and uterine cervical human papillomavirus: a meta-analysis
Xuefang Mei, Rui Zhang, Dongxian Li, Xianghuan Xie, Yi Yao, Minghui Gao, Linfei Zhao, Shengyun Zhu, Xiaowei Tian, Zhenke Yang, Shuai Wang, Zhenchao Zhang
Journal of Obstetrics and Gynaecology  vol: 43  issue: 1  year: 2023  
doi: 10.1080/01443615.2023.2194986

11. A molecular dynamics investigation into the mechanisms of tvMyb2 recognizes and binds ap65-1
Weikang LI, Qingchuan ZHENG
Minerva Surgery  vol: 79  issue: 1  year: 2024  
doi: 10.23736/S2724-5691.21.09336-9

12. Construction a novel detection method for Trichomonas vaginalis based on recombinant enzyme polymerase amplification targeting the Actin gene
Fakun Li, Yangyang Deng, Wanxin Sheng, Xihui Gao, Weijuan Wang, Zhili Chu, Xuefang Mei, Zhenke Yang, Xiaowei Tian, Shuai Wang, Zhenchao Zhang
Journal of Eukaryotic Microbiology  vol: 70  issue: 3  year: 2023  
doi: 10.1111/jeu.12963

13. Trichomonas vaginalis strain diversity among female sex workers in Ecuador using DNA sequence-based typing
Claire Elizabeth Broad, Luz Marina Llangari-Arizo, Kenneth Gordon Laing, Natalia Cristina Romero-Sandoval, Philip John Cooper, Syed Tariq Sadiq
BMC Infectious Diseases  vol: 26  issue: 1  year: 2025  
doi: 10.1186/s12879-025-12185-7

14. Association between Trichomonas vaginalis infection and spontaneous preterm labour in Lagos, Nigeria: an analytical cross-sectional study
Oyebola H. Sunmonu, Kehinde S. Okunade, Omololu Adegbola
BMC Research Notes  vol: 18  issue: 1  year: 2025  
doi: 10.1186/s13104-025-07196-1